Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul R Gordon

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Pain Medicine (Malden, Mass.)|February 13, 2008
KnowPain-50: a tool for assessing physician pain management educationJohn M Harris, John V Fulginiti, Paul R Gordon, et al.
Family Medicine and Community Health|April 12, 2024
Storylines of family medicine III: core principles-primary care, systems and familyWilliam B Ventres, Leslie A Stone, Timothy A Joslin, et al.
American Journal of Hematology|February 6, 2024
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemiaElias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, et al.
Cancer Discovery|June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid TumorsAlexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Pain Medicine (Malden, Mass.)|February 13, 2008
KnowPain-50: a tool for assessing physician pain management educationJohn M Harris, John V Fulginiti, Paul R Gordon, et al.
Family Medicine and Community Health|April 12, 2024
Storylines of family medicine III: core principles-primary care, systems and familyWilliam B Ventres, Leslie A Stone, Timothy A Joslin, et al.
American Journal of Hematology|February 6, 2024
Single agent subcutaneous blinatumomab for advanced acute lymphoblastic leukemiaElias Jabbour, Gerhard Zugmaier, Vaibhav Agrawal, et al.
Cancer Discovery|June 5, 2017
A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion-Positive Solid TumorsAlexander Drilon, Ramamoorthy Nagasubramanian, James F Blake, et al.
Pageof 2